The earnings call reflected a strong start to 2025, with significant revenue growth in the Zola brand and effective cost control measures. However, challenges such as a decline in gross margin and an increase in inventory and cash consumption were noted. The pending business combination with Roosevelt Resources is a positive development, enhancing future prospects.

Company Guidance -

Q3 2025

During the Arcadia Biosciences, Inc. first-quarter 2025 conference call, significant growth and strategic shifts were highlighted. The company reported a remarkable 90% year-over-year increase in revenue for its Zola coconut water, primarily due to a 70% rise in new distribution channels. Operating expenses saw a 16% reduction, despite incurring nearly half a million dollars in transaction-related fees. The gross margin stood at 43%, maintaining a trend of exceeding 30% for nine consecutive quarters. Arcadia continued to monetize its intellectual property, securing $750,000 in cash for certain soy patents, which allowed for the elimination of a $1,000,000 contingent liability. The pending business combination with Roosevelt Resources is progressing, aiming for completion by late summer, with a fixed equity share ratio of 90-10 between Roosevelt Partners and Arcadia stockholders. The call also mentioned a strong pipeline and new product innovations expected to further boost Zola's market presence. Overall, the company is focused on streamlining operations and enhancing financial performance in 2025.

Zola Revenue Growth

Zola coconut water revenue grew 90% year-over-year, driven by a 70% increase in new distribution gains.

Strong Pipeline and Distribution Expansion

Zola is in discussions with new customers and distributors, representing more than 50% of its current customer base, and has already won new customer accounts in Q2.

Cost Control and Operating Expense Reduction

Operating expenses were reduced by 16% year-over-year, inclusive of transaction-related fees.

Monetization of Intellectual Property

Arcadia entered an agreement with BioSeries, resulting in $750,000 in cash and the elimination of a $1,000,000 contingent liability from the balance sheet.

Pending Business Combination

The business combination with Roosevelt Resources is on track to be completed by the end of the summer, providing Arcadia stockholders with a greater level of ownership certainty post-transaction.

Arcadia Biosciences (RKDA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

RKDA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 12, 2025	2025 (Q3)	-0.54 / -	-1.18	―	―	―
Aug 14, 2025	2025 (Q2)	-0.79 / -3.26	0.78	-517.95% (-4.04)	―	―
May 08, 2025	2025 (Q1)	-0.98 / 1.90	-1.78	206.74% (+3.68)	―
Mar 20, 2025	2024 (Q4)	-0.89 / -2.98	-2.1	-41.90% (-0.88)	―
Nov 12, 2024	2024 (Q3)	-0.81 / -1.18	-1.89	37.57% (+0.71)	―
Aug 13, 2024	2024 (Q2)	1.55 / 0.78	0.61	27.87% (+0.17)	―
May 09, 2024	2024 (Q1)	-2.21 / -1.78	-7.795	77.16% (+6.01)	―
Mar 28, 2024	2023 (Q4)	-2.58 / -2.10	-6.31	66.72% (+4.21)	―
Nov 09, 2023	2023 (Q3)	-2.93 / -1.89	-4.8	60.63% (+2.91)	―
Aug 10, 2023	2023 (Q2)	-4.84 / 0.61	-6.8	108.97% (+7.41)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

RKDA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 14, 2025	$4.40	$4.65	+5.68%
May 08, 2025	$4.30	$4.29	-0.23%
Mar 20, 2025	$3.30	$3.15	-4.55%
Nov 12, 2024	$4.24	$4.19	-1.18%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Arcadia Biosciences (RKDA) report earnings?

Arcadia Biosciences (RKDA) is schdueled to report earning on Nov 12, 2025, After Close (Confirmed).

What is Arcadia Biosciences (RKDA) earnings time?

Arcadia Biosciences (RKDA) earnings time is at Nov 12, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is RKDA EPS forecast?

RKDA EPS forecast for the fiscal quarter 2025 (Q3) is -0.54.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing